Pathological reports show that AD is characterized by deposition beta-amyloid (Aβ) plaques, reactive oxygen species (ROS), reduction in acetylcholine (ACh), hyper-phosphorylated tau proteins and glutamatergic abnormalities (Ahmad et al. 2018; Ovais et al. 2018). This evidence concerns the gene MAPT and Alzheimer disease.